CDX-622

DRUG2 trials

Sponsors

Celldex Therapeutics

Conditions

Healthy ParticipantsMild to Moderate Asthma

Phase 1

A Phase I Study of CDX-622

CompletedNCT06650761

Celldex TherapeuticsHealthy Participants

Start: 2024-11-01End: 2026-04-24Updated: 2026-05-04

A Study of CDX-622 in Participants With Mild to Moderate Asthma

RecruitingNCT07330778

Celldex TherapeuticsMild to Moderate Asthma

Start: 2026-06-01End: 2027-03-01Target: 12Updated: 2026-07-02